Search Clinical Trials
605,319 trials
ID
Status
Phase
Title
Sponsor
NCT07853781
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy VolunteersNational Institute of Mental Health (NIMH)RecruitingPhase 1
NCT07853781Recruiting
Phase 1
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy Volun...National Institute of Men...
NCT07855692
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)Nagoya UniversityNot Yet RecruitingPhase 2
NCT07855692Not Yet Recruiting
Phase 2
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)Nagoya University
NCT07856628
Sex Differences in Heart Rate Variability Responses to Eight Weeks of Circuit TrainingUniversiti Sains MalaysiaCompletedNot Applicable
NCT07856628Completed
Not Applicable
Sex Differences in Heart Rate Variability Responses to Eight Weeks of Circuit Tr...Universiti Sains Malaysia
NCT07856576
Effect of a Social-Support-Based Educational Intervention on COVID-19-Related Anxiety and Perceived Social Support in Pregnant Women: A Randomized Pretest-Posttest Controlled TrialAtefeh DehnoalianCompletedNot Applicable
NCT07856576Completed
Not Applicable
Effect of a Social-Support-Based Educational Intervention on COVID-19-Related An...Atefeh Dehnoalian
NCT07854600
A Phase II Study of Ivonescimab in Combination With GEMOX as Neoadjuvant and Conversion Therapy for Biliary Tract CancerHaitao Zhao, MDRecruitingPhase 2
NCT07854600Recruiting
Phase 2
A Phase II Study of Ivonescimab in Combination With GEMOX as Neoadjuvant and Con...Haitao Zhao, MD
NCT07855926
Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)LMU KlinikumRecruiting
NCT07855926Recruiting
—
Perioperative Systemic Therapies in Muscle-Invasive Bladder Cancer (GUARDIANS)LMU Klinikum
NCT07856511
A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumatoid ArthritisJiankuan (Suzhou) Biotechnology Company LimitedNot Yet RecruitingPhase 3
NCT07856511Not Yet Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheumat...Jiankuan (Suzhou) Biotech...
NCT07854925
Protective Factors for Well-being in Endometriosis PatientsMaximiliane UhlichNot Yet RecruitingNot Applicable
NCT07854925Not Yet Recruiting
Not Applicable
Protective Factors for Well-being in Endometriosis PatientsMaximiliane Uhlich
NCT07854119
Kendall Exercises With and Without Positional Release Therapy in Upper Crossed SyndromeRiphah International UniversityRecruitingNot Applicable
NCT07854119Recruiting
Not Applicable
Kendall Exercises With and Without Positional Release Therapy in Upper Crossed S...Riphah International Univ...
NCT07855809
Kinesio Taping for Pain and Recovery After Cesarean DeliveryIbrahim Ethem KirezCompletedNot Applicable
NCT07855809Completed
Not Applicable
Kinesio Taping for Pain and Recovery After Cesarean DeliveryIbrahim Ethem Kirez
NCT07853963
Invasive Versus Non-Invasive Intracranial Pressure-Guided Management in Neurosurgical PatientsKathmandu Medical College and Teaching HospitalCompletedNot Applicable
NCT07853963Completed
Not Applicable
Invasive Versus Non-Invasive Intracranial Pressure-Guided Management in Neurosur...Kathmandu Medical College...
NCT07854158
Unilateral Spinal Anesthesia vs Popliteal-Adductor Canal Block for Below-knee AmputationSargodha Medical CollegeNot Yet RecruitingNot Applicable
NCT07854158Not Yet Recruiting
Not Applicable
Unilateral Spinal Anesthesia vs Popliteal-Adductor Canal Block for Below-knee Am...Sargodha Medical College
NCT07854223
Effects of Pre-Run Nutritional Supplements During a Fixed-Pace 5 km Treadmill RunSt. Louis UniversityRecruitingNot Applicable
NCT07854223Recruiting
Not Applicable
Effects of Pre-Run Nutritional Supplements During a Fixed-Pace 5 km Treadmill Ru...St. Louis University
NCT07854808
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney DiseaseThe University of QueenslandNot Yet Recruiting
NCT07854808Not Yet Recruiting
—
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to...The University of Queensl...
NCT07854860
Four-Week Multicomponent Exercise Program in Older AdultsPoznan University of Physical EducationCompletedNot Applicable
NCT07854860Completed
Not Applicable
Four-Week Multicomponent Exercise Program in Older AdultsPoznan University of Phys...
NCT07856355
Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated PneumoniaFirst Affiliated Hospital of Zhejiang UniversityNot Yet RecruitingPhase 4
NCT07856355Not Yet Recruiting
Phase 4
Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pne...First Affiliated Hospital...
NCT07854015
LI4 Acupuncture for Pain During Intrauterine Device InsertionNigde Omer Halisdemir UniversityNot Yet RecruitingNot Applicable
NCT07854015Not Yet Recruiting
Not Applicable
LI4 Acupuncture for Pain During Intrauterine Device InsertionNigde Omer Halisdemir Uni...
NCT07854652
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic LeukemiaGuangzhou BeBetter Med Co., LtdRecruitingPhase 1
NCT07854652Recruiting
Phase 1
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precurso...Guangzhou BeBetter Med Co...
NCT07855627
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance MeasurementsM.D. Anderson Cancer CenterRecruiting
NCT07855627Recruiting
—
Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preope...M.D. Anderson Cancer Cent...
NCT07856394
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid TumorsMayo ClinicRecruitingNot Applicable
NCT07856394Recruiting
Not Applicable
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation...Mayo Clinic
Result Breakdown
Recruiting8 (40%)
Not yet recruiting7 (35%)
Completed5 (25%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 12 (10%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)